Anti-cancer oncolytic activity of respiratory syncytial virus

Oncolytic virotherapy is an emerging bio-therapeutic platform for cancer treatment, which is based on selective infection/killing of cancer cells by viruses. Herein we identify the human respiratory syncytial virus (RSV) as an oncolytic virus. Using prostate cancer models, we show dramatic enhanceme...

Descripción completa

Detalles Bibliográficos
Autores principales: Echchgadda, I, Kota, S, Cruz, I DeLa, Sabbah, A, Chang, T, Harnack, R, Mgbemena, V, Chatterjee, B, Bose, S
Formato: Texto
Lenguaje:English
Publicado: 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813688/
https://www.ncbi.nlm.nih.gov/pubmed/19444304
http://dx.doi.org/10.1038/cgt.2009.34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813688/
https://www.ncbi.nlm.nih.gov/pubmed/19444304
http://dx.doi.org/10.1038/cgt.2009.34

Ejemplares similares